HY1 Stock Overview
Operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Ontrak, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.30 |
| 52 Week High | US$0.65 |
| 52 Week Low | US$0.26 |
| Beta | 2.64 |
| 1 Month Change | 14.50% |
| 3 Month Change | -36.44% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -35.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| HY1 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 3.4% | -2.3% | -3.1% |
| 1Y | n/a | 3.8% | -0.5% |
Return vs Industry: Insufficient data to determine how HY1 performed against the German Healthcare industry.
Return vs Market: Insufficient data to determine how HY1 performed against the German Market.
Price Volatility
| HY1 volatility | |
|---|---|
| HY1 Average Weekly Movement | 32.0% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: HY1's share price has been volatile over the past 3 months.
Volatility Over Time: HY1's weekly volatility has increased from 24% to 32% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 103 | Brandon LaVerne | www.ontrakhealth.com |
Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company’s technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure.
Ontrak, Inc. Fundamentals Summary
| HY1 fundamental statistics | |
|---|---|
| Market cap | €11.13m |
| Earnings (TTM) | -€30.82m |
| Revenue (TTM) | €12.05m |
0.9x
P/S Ratio-0.4x
P/E RatioIs HY1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HY1 income statement (TTM) | |
|---|---|
| Revenue | US$12.89m |
| Cost of Revenue | US$4.07m |
| Gross Profit | US$8.82m |
| Other Expenses | US$41.81m |
| Earnings | -US$32.98m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.69 |
| Gross Margin | 68.43% |
| Net Profit Margin | -255.79% |
| Debt/Equity Ratio | 11.8% |
How did HY1 perform over the long term?
See historical performance and comparison